YOLFTbeta
30

Zhongjin Irradiation Incorporated Company

300962 · SHE · Industrials / Specialty Industrial Machinery

13.50CNY-0.44 (-3.16%)

Price History

Full chart

Market Stats

Previous Close13.94
Open13.44
Day Range13.37 – 13.87
52-Week Range11.69 – 19.75
Volume5.35M
Market Cap3.41B
P/E (TTM)35.86
Forward P/E0.00
EPS0.36
Dividend Yield0.70%
Beta0.24
50-Day Avg13.05
200-Day Avg15.04

About

Zhongjin Irradiation Incorporated Company provides irradiation technology services in China. It provides irradiation sterilization services for medical and health care products, food, pharmaceuticals, daily necessities, packaging materials, and other products; irradiation modification services for polymer materials; scientific and sterilization technology solutions; and disinfection and sterilization services for reusable diagnostic and treatment instruments, equipment, nursing kits, and surgical packs. The company also provides inspection and testing services, such as testing, verification and consulting services for irradiation technology services. Zhongjin Irradiation Incorporated Company was incorporated in 2003 and is headquartered in Shenzhen, China.

Company Details

  • SectorIndustrials
  • IndustrySpecialty Industrial Machinery
  • CEOMr. Zhengjin Liu
  • Employees672
  • HeadquartersNo. 1028, Building B, Buji Road, Shenzhen, China, 518019, China
  • Websitehttps://zjfz.chinagoldgroup.com

Leadership

  • Mr. Zhengjin LiuChief Accountant · b. 1978
  • Mr. Jun ChenDeputy GM, Secretary, General Counsel & Chief Compliance Officer · b. 1977

Financials

Income Statement

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue133.82M156.47M189.79M206.78M214.21M243.69M253.26M255.96M309.07M337.13M344.75M358.51M364.03M
Growth (%)-+16.93%+21.29%+8.96%+3.59%+13.76%+3.93%+1.07%+20.75%+9.08%+2.26%+3.99%+1.54%
Cost of Revenue53.08M69.30M86.09M88.91M93.94M110.04M110.06M111.68M121.00M123.20M126.73M134.33M146.30M
Gross Profit80.74M87.17M103.70M117.87M120.27M133.65M143.20M144.28M188.07M213.93M218.02M224.19M217.72M
Gross Margin60.33%55.71%54.64%57.00%56.15%54.85%56.54%56.37%60.85%63.46%63.24%62.53%59.81%
Operating Expense49.03M58.47M64.42M68.48M74.62M73.83M74.48M71.47M77.79M86.35M90.51M94.05M71.93M
Operating Income31.71M28.70M39.28M49.39M45.65M59.82M68.72M72.82M110.28M127.58M127.52M130.13M145.80M
Operating Margin23.70%18.34%20.70%23.89%21.31%24.55%27.13%28.45%35.68%37.84%36.99%36.30%40.05%
EBITDA572.46M824.22M985.33M55.37M60.56M73.13M139.44M141.49M176.49M191.53M195.42M200.27M244.02M
EBITDA Margin427.80%526.76%519.18%26.78%28.27%30.01%55.06%55.28%57.10%56.81%56.68%55.86%67.03%
Net Income26.71M20.35M29.98M31.32M38.90M52.50M58.31M61.54M87.12M107.73M108.08M108.87M118.56M
Net Income Margin19.96%13.01%15.80%15.15%18.16%21.54%23.02%24.04%28.19%31.95%31.35%30.37%32.57%
R&D8.50M11.72M10.85M11.43M10.69M15.07M15.60M17.84M21.09M25.76M25.81M28.31M29.90M
R&D as % of Total Revenue6.35%7.49%5.72%5.53%4.99%6.18%6.16%6.97%6.82%7.64%7.49%7.90%8.21%
Interest Expense8.18M9.59M8.49M10.86M10.16M7.49M4.32M3.91M2.70M2.15M1.75M2.46M2.44M
Interest Expense % of Total Revenue6.11%6.13%4.47%5.25%4.74%3.07%1.70%1.53%0.87%0.64%0.51%0.69%0.67%

Balance Sheet

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets696.62M691.39M747.91M746.24M739.79M758.07M759.03M730.07M1.00B1.07B1.10B1.14B1.32B
Total Liabilities255.51M227.80M253.08M234.79M190.20M141.37M132.54M100.59M124.23M152.29M151.78M155.46M242.21M
Total Equity422.23M442.58M472.56M483.88M522.77M589.93M598.74M601.18M845.55M887.28M916.16M948.47M1.03B
Cash68.61M25.34M55.84M50.43M39.38M86.73M62.00M38.14M315.46M321.76M353.16M313.84M266.67M
Total Debt115.95M64.00M132.50M126.00M100.00M60.00M50.00M30.00M9.53M7.94M10.89M6.60M-
Net Debt47.34M38.66M76.66M75.57M60.62M-26.73M-12.00M-7.27M-305.93M-313.83M-342.27M-307.24M-

Cash Flow

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow77.36M123.21M112.99M-126.40M147.18M125.90M140.52M175.55M185.43M188.38M194.01M217.48M
Investing Cash Flow-212.11M-105.68M-101.77M-93.53M-104.15M-63.66M-85.51M-82.80M-61.77M-118.04M-78.00M-163.74M-
Financing Cash Flow132.26M-60.80M18.95M-32.26M-33.35M-36.12M-65.09M-81.58M163.54M-61.09M-78.99M-69.60M-
Capital Expenditure212.14M105.71M101.97M96.97M107.85M69.12M89.04M84.51M65.07M118.04M85.27M163.72M305.13M
Free Cash Flow-134.78M17.50M11.02M-96.97M18.55M78.06M36.86M56.00M110.48M67.39M103.11M30.29M-87.65M
Dividends Paid8.64M8.85M7.85M25.76M5.55M44.34M51.33M60.73M39.19M66.00M73.88M69.21M35.38M
FCF to OCF-174.23%14.21%9.75%-14.67%53.04%29.28%39.86%62.93%36.34%54.73%15.61%-40.30%
Dividend Paid to FCF-6.41%50.56%71.28%-26.56%29.92%56.80%139.28%108.44%35.47%97.94%71.65%228.51%-40.36%

Earnings

Report DateJun 30, 2021Sep 30, 2021Dec 31, 2021Apr 26, 2022Sep 8, 2022Oct 25, 2022Dec 31, 2022May 5, 2023Aug 28, 2023Dec 28, 2023Jan 29, 2024May 28, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate---------------------
EPS Actual0.110.110.020.110.120.130.050.110.130.120.040.110.130.120.050.100.150.090.110.090.07
Surprise---------------------
Timing---Pre-marketAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours---------

Key Statistics & Ratios

Market Cap3.41B
Enterprise Value3.24B
Trailing P/E35.86
Forward P/E0.00
Price / Sales9.32
Price / Book3.31
EPS0.36
Book Value3.96
Revenue (TTM)365.87M
Gross Profit (TTM)211.99M
EBITDA195.41M
Profit Margin25.76%
Operating Margin28.35%
Return on Equity9.18%
Return on Assets4.36%
Shares Outstanding264.00M
Shares Float111.77M
Beta0.24
Dividend Yield0.70%
Dividend Rate0.09
Payout Ratio25.22%

Dividends

20261×
0.09Jul 27, 2026
20251×
0.15Jun 30, 2025
20241×
0.29Jun 19, 2024
20231×
0.30Jun 7, 2023
20222×
0.15Dec 23, 20220.10Jun 10, 2022
20211×
0.16Jun 10, 2021